eli lilly zepbound tirzepatide says weight loss drug cuts heart failure risk by 38% in trial Eli Lilly Launches Self-Pay Vials

Second, the FDA explicitly named HIMS, which is virtually unprecedented in a Commissioner-level statement

As part of the prior authorization process for Bridge, prescribing clinicians will need to attest that the GLP-1 prescription is for weight reduction and weight management and that beneficiaries meet the clinical criteria and do not have a diagnosis of type 2 diabetes, OSA, or MASH that would make them eligible for GLP-1 coverage under Part D

When Your Medication Actually Works Best Heres what I figured out about when semaglutide actually works throughout the day (and when it doesnt)

If youre worried, speak to your GP